CIK: 0001281446 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 13, 2024
Total Value ($000): $339,762 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NGNE | NEUROGENE INC | 1,004,291 | $42,140 | 12.4% | $14.51 | +167.3% | COM | 64135M105 |
| ABVX | ABIVAX SA | 2,128,773 | $24,523 | 7.2% | $12.06 | — | SPONSORED ADS | 00370M103 |
| PLRX | PLIANT THERAPEUTICS INC | 1,910,121 | $21,412 | 6.3% | $16.18 | -22.7% | COM | 729139105 |
| EOLS | EVOLUS INC | 1,170,000 | $18,954 | 5.6% | $9.65 | +44.8% | COM | 30052C107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 750,000 | $17,063 | 5.0% | $18.37 | -11.0% | COM | 92790C104 |
| CYTK | CYTOKINETICS INC | 316,000 | $16,685 | 4.9% | $51.75 | +7.7% | COM NEW | 23282W605 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,299,503 | $15,048 | 4.4% | $11.67 | +7.8% | COM | 483497103 |
| — | DYNAVAX TECHNOLOGIES CORP | 1,326,234 | $14,774 | 4.3% | $11.86 | — | COM NEW | 268158201 |
| CNTX | CONTEXT THERAPEUTICS INC | 6,934,982 | $13,593 | 4.0% | $1.72 | +28.7% | COM | 21077P108 |
| ZURA | ZURA BIO LTD | 3,263,672 | $13,251 | 3.9% | $6.43 | -41.9% | CLASS A ORD SHS | G9TY5A101 |
| ORKA | ORUKA THERAPEUTICS INC | 514,659 | $12,614 | 3.7% | $34.79 | 0.0% | COM | 687604108 |
| — | MERUS N V | 250,000 | $12,490 | 3.7% | $52.47 | — | COM | N5749R100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,000,000 | $11,940 | 3.5% | $11.24 | +13.8% | COM | 68062P106 |
| IONS | IONIS PHARMACEUTICALS INC | 255,000 | $10,215 | 3.0% | $41.01 | +13.4% | COM | 462222100 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2,811,955 | $10,207 | 3.0% | $4.46 | — | SPON ADS | 05280R100 |
| URGN | UROGEN PHARMA LTD | 758,786 | $9,637 | 2.8% | $15.87 | -6.5% | COM | M96088105 |
| — | OPTINOSE INC | 12,861,136 | $8,617 | 2.5% | $1.52 | — | COM | 68404V100 |
| ACLX | ARCELLX INC | 100,000 | $8,351 | 2.5% | $56.99 | +16.8% | Put | 03940C100 |
| ACLX | ARCELLX INC | 100,000 | $8,351 | 2.5% | $56.99 | +16.8% | COMMON STOCK | 03940C100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 275,000 | $7,530 | 2.2% | $22.14 | +25.8% | COM | 252828108 |
| OTLK | OUTLOOK THERAPEUTICS INC | 1,293,028 | $6,905 | 2.0% | $8.08 | -9.4% | COM | 69012T305 |
| JSPR | JASPER THERAPEUTICS INC | 322,380 | $6,064 | 1.8% | $17.76 | +12.1% | COM NEW | 471871202 |
| VYGR | VOYAGER THERAPEUTICS INC | 959,953 | $5,616 | 1.7% | $7.91 | — | COM | 92915B106 |
| BBOT | HELIX ACQUISITION CORP II | 500,000 | $5,225 | 1.5% | $10.35 | +0.1% | CL A ORD SHS | G4444H101 |
| TCRX | TSCAN THERAPEUTICS INC | 1,016,375 | $5,062 | 1.5% | $7.74 | -22.0% | COM | 89854M101 |
| — | UNICYCIVE THERAPEUTICS INC | 8,559,000 | $3,491 | 1.0% | $0.41 | — | COM | 90466Y103 |
| — | PROMIS NEUROSCIENCES INC | 2,790,698 | $3,488 | 1.0% | $1.25 | — | COM NEW | 74346M406 |
| RNAC | CARTESIAN THERAPEUTICS INC | 200,000 | $3,224 | 0.9% | $15.62 | 0.0% | COM NEW | 816212302 |
| VTGN | VISTAGEN THERAPEUTICS INC | 674,075 | $2,029 | 0.6% | $3.78 | -9.8% | COM | 92840H400 |
| CLYM | ELIEM THERAPEUTICS INC | 248,168 | $1,263 | 0.4% | $7.07 | 0.0% | COM | 28658R106 |